Spring direct naar de hoofdnavigatie of de inhoud
‘In the end it's all about the value that the patent adds to the product.’
Mark Einerhand

Mark Einerhand

  • Life Sciences
  • European and Dutch Patent Attorney
  • Partner

Mark Einerhand has been active in the patent world since 1998, when he made the switch from a biotech startup to V.O.

Mark’s career started in science. After his studies of molecular biology at the University of Amsterdam, he took his PhD in medical science inLeiden, in 1992. He was a visiting scientist at Cornell University in New York and the MRC at Mill Hill in London.

Continue reading

His particular expertise lies in the field of medical (bio)technology, diagnostics and medicines. Because of his background at Introgene/Crucell, Mark has a special affinity with Life Science startups. He has a wide experience in patent cases before the court in The Hague.

Working experience

  • Patent Attorney, V.O. (1998-present)
  • IntroGene (now Crucell), Rijswijk (1995)
  • Post-Doc at Leiden University (1993)
  • Medical Research Council, Mill Hill, London (1992)
  • Visiting Scientist, Cornell University New York (1992)

Education

  • PhD in Medicine, Leiden University (1992)
  • MSc in Biochemistry, University of Amsterdam (1987), Major in Molecular Oncology, Dutch Cancer Institute

Publications

  • Co-author of article ‘The patentability of stem cells in Europe’, IAM Life Sciences 2015.
    Einerhand, M.P.W. (2011): Advance offering of generics found to infringe. Managing Intellectual Property: Vol 205: page: 87.
  • Einerhand M.P.W. (2010): A contribution to: Legal and intellectual property issues associated with stem cells. In: Stem Cells; scientific facts and fiction, (C. Mummery; I. Wilnut, A van de Stolpe and
    B.A.J. Roelen), Academic Press: Elsevier.
  • Einerhand M.P.W. and van Melle, J (2004): Patenting of inventions in the field of bio-informatics.
    In: The new avenues in Bioinformatics, (Seckbach, J and Rubin, E eds), Kluwer Academic Publishers, the Netherlands.
  • Principle inventor on Patents and Patent Applications: Einerhand, M.P.W. and Valerio (1997). WO 98/32870: US 6,232,105: A conditional replication and expression system. Einerhand, M.P.W. and Valerio (1997). WO 99/32647: Adeno-associated virus and adenovirus chimeric recombinant viruses useful for the integration of foreign genetic information into chromosomal DNA of target cells in gene therapy. Einerhand, M.P.W. and Valerio (1996). WO98/24924: NZ 336185:
  • Transduction of primate hemopoietic repopulating stem cells. Einerhand, M.P.W. and Valerio (1995). WO 97/20943: US 6,140,103: Regulated protein expression in stably transfected mammalian cells. Einerhand, M.P.W. (1992) Gene transfer into hemopoietic stem cells: prospects for human gene therapy. University of Leiden.

Professional & Community Activities

  • Member of the Steering Committee World IP Forum 2015
    Former member of the European Qualifying Examination committee III

Languages

  • English
  • Dutch
  • German

Also see these experts

Saskia van Doorn

Saskia van Doorn

  • European and Dutch Patent Attorney
  • Senior Associate
Bettina Hermann

Bettina Hermann

  • European and German Patent and Trademark Attorney
  • Partner
More experts

News

New European patent system launched

As of 1 June, the new European patent system is in force and the Unified Patent Court (UPC) finally opens its doors. This completes the preparations that had begun back in 1975 to create a truly European patent court.Continue reading

The Legal Quick Scan – your documents in order

Within your organization, various legal documents circulate daily – from employment contract to license and NDA. But is your company’s intellectual property contractually well regulated in these documents­? With the Legal Quick Scan we can assess this for you quickly and at a fixed rate.Continue reading

Your European patent: file an opt-out or not?

When the unitary patent and the Unified Patent Court (UPC) come into force on June 1 this year, all European patents can be involved in enforcement proceedings before this new European Patent Court. This court will then decide enforcement measures and invalidity proceedings in all 17 EU countries at once.Continue reading

Events

BIO International Convention 2023

Boston Convention and Exhibition Center, Summer Street, Boston, MA, USA

The BIO International Convention attracts 14,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships.

Continue reading

Grand Finale of TU Delft Impact Contest 2023

TNO - Locatie Delft - Molengraaffsingel (Next Delft), Molengraaffsingel, Delft, Netherlands

Since 2019, the TU Delft Impact Contest offers students the opportunity to further develop their own ingenious ideas, prototypes and research projects into business plans. The main goal and mission is to challenge students to come up with great innovative solutions to societal problems out-of-the-box, and translate them into real products and business plans.

Continue reading

Grand Finale UT Entrepreneurial Challenge 2023

Muziekcentrum Enschede, Noorderhagen, Enschede

Since 2017, the UT Entrepreneurial Challenge has offered students the opportunity to further develop their own ingenious ideas, prototypes and research projects into business plans. The main goal and mission is to challenge students to come up with great innovative solutions to societal problems out-of-the-box, and translate them into real products and business plans.

Continue reading